3.0
Jul 12, 2024
Former employee, less than 1 year
Recommend
CEO approval
Business Outlook
Pros
Resource heavy Science/helping people with new drug options 2 week-long company shut downs
Cons
Poor management - large re-org on the team left people with no management experience having to manage people Strict SOPs, no room for thinking outside the box for solutions.